ARTICLE | Clinical News
XOMA Corp. regulatory update
January 22, 1996 8:00 AM UTC
XOMA received U.S. Patent No. 5,484,705 covering methods of measuring Lipopolysaccharide Binding Protein (LBP) in human blood. LBP belongs to a class of plasma proteins called acute phase proteins, wh...